Company: INDP
Filing Date: 2025-02-05
Form Type: S-3
Source: 0001493152-25-005016
Chunk: 21

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-02-05
Form: S-3
Chunk 21
---
, or the warrant shares, are not registered under the Securities Act, elect instead to receive upon such exercise (either in whole or in part) the net number of shares of common stock determined according to a formula set forth in the warrant.

| 14 |

Rights as a Stockholder

Except as otherwise provided in the warrant or by virtue of such holder’s ownership of common stock, the holders of the warrant do not have the rights or privileges of holders of our common stock, including any voting rights, until they exercise the warrant.

Anti-takeover Effects of Certain Provisions of the Amended and Restated Certificate of Incorporation and the Amended and Restated Bylaws

General

The Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws contains provisions that are intended to enhance the likelihood of continuity and stability in the composition of our board of directors and that could make it more difficult to acquire control of us by means of a tender offer, open market purchases, a proxy contest or otherwise. A description of these provisions is set forth below.

Delaware Anti-Takeover Law

We are subject to Section 203 of the Delaware General Corporation Law. Section 203 generally prohibits a public Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date of the transaction in which the person became an interested stockholder, unless:

| ● | prior                                                                                                                                 
 to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction 
 which resulted in the stockholder becoming an interested stockholder;                                                                 |
| ● | upon                                                                                                                                  
 consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned 
 at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding specified shares;    
 or                                                                                                                                    |
| ● | at                                                                                                                                    
 or subsequent to the date of the transaction, the business combination is approved by the board of directors and authorized at an     
 annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding 
 voting stock which is not owned by the interested stockholder.                                                                        |

Section 203 defines a “business combination” to include:

| ● | any                                                                                                                                   
 merger or consolidation involving the corporation and the interested stockholder;                                                     |
| ● | any                                                                                                                                   
 sale, lease, exchange, mortgage